fda warning letters compounded semaglutide tirzepatide 2024 2025 🚨 Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these U.S. FDA sends drug advertising

T., & McIntyre, R

Ive never been a person that thinks about food or their next meal, because as a professional athlete, thats never what I think about

The Times story described patients using alternative sources for these drugs (telehealth companies) who used compounding pharmacies to prepare much smaller doses than the branded options marketed by the drug companies

GABAergic excitation of vasopressin neurons: possible mechanism underlying sodium-dependent hypertension

Corrects glutathione deficiencies (associated with aging)

These target specific organ systems and have a unique mechanism involving gene expression modulation